Kim Kelderman

Director; Director, Chief Executive Officer · 3 filings · Latest: Jul 28, 2026

BIO-TECHNE Corp

CONMED Corp

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TECH	Kim Kelderman	Director, Chief Executive Officer	Jul 28, 2026	Option Exercise	$47.60	35,000	$1.7M	100,799	Jul 30 8:11 PM
TECH	Kim Kelderman	Director, Chief Executive Officer	May 5, 2026	Option Exercise	$47.60	26,692	$1.3M	89,750	May 7 9:22 PM